Related Experiment Video
Updated: Feb 9, 2026

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
Published on: January 6, 2023
Gallic acid targets acute myeloid leukemia via Akt/mTOR-dependent mitochondrial respiration inhibition
Ruixin Gu1, Minqin Zhang1, Hu Meng2
1Department of Traditional Chinese Medicine, Wuhan Forth Hospital, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Abstract:
Gallic acid is one of the many phenolic acids that can be found in dietary substances and traditional medicine herbs. The anti-cancer activities of gallic acid have been shown in various cancers but its underlying molecular mechanisms are not well understood. In this study, we show Akt/mammalian target of rapamycin (mTOR)-dependent inhibition of mitochondrial respiration as a mechanism of gallic acid's action in acute myeloid leukemia (AML). Gallic acid significantly induces apoptosis of AML cell lines, primary mononuclear cells (MNC) and CD34 stem/progenitors isolated form AML patients via caspase-dependent pathway. It also significantly enhances two standard AML chemotherapeutic agents' efficacy in vitro cell culture system and in vivo xenograft model. Gallic acid inhibits dose- and time-dependent mitochondrial respiration, leading to decreased ATP production and oxidative stress. Overexpression of constitutively active Akt restores gallic acid-mediated inhibition of mTOR signaling, mitochondrial dysfunction, energy crisis and apoptosis. Our results demonstrate that mitochondrial respiration inhibition by gallic acid is a consequence of Akt/mTOR signaling suppression. Our findings suggest that combination therapy with gallic acid may enhance antileukemic efficacy of standard chemotherapeutic agents in AML.
Insights
Gallic acid induces apoptosis in acute myeloid leukemia (AML) cells by inhibiting mitochondrial respiration through the Akt/mammalian target of rapamycin (mTOR) pathway. This natural compound enhances standard chemotherapy efficacy, offering a potential combination therapy for leukemia.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Gallic acid, a phenolic compound, exhibits anti-cancer properties, but its molecular mechanisms in acute myeloid leukemia (AML) remain unclear.
- Understanding gallic acid's action is crucial for developing novel therapeutic strategies against AML.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying gallic acid's anti-leukemic effects in AML.
- To investigate gallic acid's impact on mitochondrial respiration and its interaction with the Akt/mammalian target of rapamycin (mTOR) signaling pathway.
- To evaluate gallic acid's potential as an adjunct therapy in AML treatment.
Main Methods:
- Investigated gallic acid's effects on AML cell lines, primary mononuclear cells (MNC), and CD34 stem/progenitors.
- Assessed apoptosis induction via caspase-dependent pathways.
- Measured mitochondrial respiration, ATP production, and oxidative stress.
- Utilized in vitro cell culture and in vivo xenograft models to evaluate combination therapy efficacy.
- Examined the role of the Akt/mTOR signaling pathway using constitutively active Akt overexpression.
Main Results:
- Gallic acid significantly induced apoptosis in AML cells and patient-derived samples through a caspase-dependent pathway.
- Gallic acid inhibited mitochondrial respiration in a dose- and time-dependent manner, decreasing ATP production and increasing oxidative stress.
- The Akt/mTOR signaling pathway was identified as a key mediator; Akt activation reversed gallic acid's effects on mTOR signaling, mitochondrial function, and apoptosis.
- Gallic acid demonstrated synergistic effects with standard AML chemotherapeutic agents in both in vitro and in vivo models.
Conclusions:
- Gallic acid exerts anti-leukemic effects in AML by suppressing mitochondrial respiration via the Akt/mTOR signaling pathway.
- Gallic acid effectively induces apoptosis and enhances the efficacy of conventional chemotherapies in AML.
- Combination therapy involving gallic acid holds promise for improving treatment outcomes in acute myeloid leukemia.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Animal Mitochondrial Genetics
Respiration
Energy production in the human body is primarily fueled by oxidation, a process where food molecules are burned by combining with oxygen to produce carbon dioxide and water. This vital metabolic process sustains life, and is supported intricately by the respiratory system.
Structure and Function of the Respiratory System:
The respiratory system is a complex network of structures that includes the nose, oropharynx, larynx, trachea,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Feedback Inhibition
Export of Mitochondrial and Chloroplast Genes